Literature DB >> 19853220

Identification of pharmacoresistant epilepsy.

Anne T Berg1.   

Abstract

There is no single definition of pharmacoresistant (intractable, refractory) epilepsy. Prospective identification of pharmacoresistance is complicated by the variability of its appearance across different types of epilepsy and the variability of seizure control within a given patient over time. Failure of informative trials of two appropriate antiepileptic drugs has been recommended as a threshold that should trigger referral for evaluation at a comprehensive epilepsy center. Maximizing seizure control is imperative for reducing the risks and consequences of epilepsy, including the cognitive and psychiatric comorbidities and even sudden death.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19853220      PMCID： PMC2827183          DOI： 10.1016/j.ncl.2009.06.001

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  53 in total

1.  Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study.

Authors:  T S Walczak; I E Leppik; M D'Amelio; J Rarick; E So; P Ahman; K Ruggles; G D Cascino; J F Annegers; W A Hauser
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.

Authors:  S D Lhatoo; A L Johnson; D M Goodridge; B K MacDonald; J W Sander; S D Shorvon
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

3.  Transient seizure remission in intractable localization-related epilepsy.

Authors:  J Takenaka; K Aso; K Watanabe; A Okumura; T Negoro
Journal:  Pediatr Neurol       Date:  2000-10       Impact factor: 3.372

4.  Mortality risk in children with epilepsy: the Dutch study of epilepsy in childhood.

Authors:  P M Callenbach; R G Westendorp; A T Geerts; W F Arts; E A Peeters; C A van Donselaar; A C Peters; H Stroink; O F Brouwer
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

5.  Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.

Authors:  C Chiron; M C Marchand; A Tran; E Rey; P d'Athis; J Vincent; O Dulac; G Pons
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

Review 6.  Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons.

Authors:  J Engel; S Wiebe; J French; M Sperling; P Williamson; D Spencer; R Gumnit; C Zahn; E Westbrook; B Enos
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

7.  Evaluating the utility of inpatient video-EEG monitoring.

Authors:  Daniel F Ghougassian; Wendyl d'Souza; Mark J Cook; Terence J O'Brien
Journal:  Epilepsia       Date:  2004-08       Impact factor: 5.864

8.  Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood.

Authors:  Willem F M Arts; Oebele F Brouwer; A C Boudewijn Peters; Hans Stroink; Els A J Peeters; Paul I M Schmitz; Cees A van Donselaar; Ada T Geerts
Journal:  Brain       Date:  2004-06-16       Impact factor: 13.501

9.  Remission of epilepsy after two drug failures in children: a prospective study.

Authors:  Anne T Berg; Susan R Levy; Francine M Testa; Ramona D'Souza
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

Review 10.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910
View more
  35 in total

1.  Intractable epilepsy: relapsing, remitting, or progressive?

Authors:  Susan Herman
Journal:  Epilepsy Curr       Date:  2010-11       Impact factor: 7.500

2.  Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters.

Authors:  William D Gaillard; J Helen Cross; John S Duncan; Hermann Stefan; William H Theodore
Journal:  Epilepsia       Date:  2011-07-08       Impact factor: 5.864

3.  Linear time-varying model characterizes invasive EEG signals generated from complex epileptic networks.

Authors:  Adam Li; Kristin M Gunnarsdottir; Sara Inati; Kareem Zaghloul; John Gale; Juan Bulacio; Jorge Martinez-Gonzalez; Sridevi V Sarma
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2017-07

Review 4.  Refractory epilepsy in children.

Authors:  Satinder Aneja; Puneet Jain
Journal:  Indian J Pediatr       Date:  2014-08-09       Impact factor: 1.967

5.  Functional magnetic resonance imaging networks induced by intracranial stimulation may help defining the epileptogenic zone.

Authors:  Stephen E Jones; Myron Zhang; Rafi Avitsian; Pallab Bhattacharyya; Juan Bulacio; Fernando Cendes; Rei Enatsu; Mark Lowe; Imad Najm; Dileep Nair; Michael Phillips; Jorge Gonzalez-Martinez
Journal:  Brain Connect       Date:  2014-05

6.  An integrative prediction algorithm of drug-refractory epilepsy based on combined clinical-EEG functional connectivity features.

Authors:  Xiong Han; Bin Wang; Shijun Yang; Pan Zhao; Mingmin Li; Zongya Zhao; Na Wang; Huan Ma; Yue Zhang; Ting Zhao; Yanan Chen; Zhe Ren; Yang Hong; Qi Wang
Journal:  J Neurol       Date:  2021-07-25       Impact factor: 4.849

7.  Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts.

Authors:  Blair H Smith; Nicola Torrance; Janice A Ferguson; Michael I Bennett; Michael G Serpell; Kate M Dunn
Journal:  BMC Neurol       Date:  2012-05-28       Impact factor: 2.474

8.  Increased metallothionein I/II expression in patients with temporal lobe epilepsy.

Authors:  José Eduardo Peixoto-Santos; Orfa Yineth Galvis-Alonso; Tonicarlo Rodrigues Velasco; Ludmyla Kandratavicius; João Alberto Assirati; Carlos Gilberto Carlotti; Renata Caldo Scandiuzzi; Luciano Neder Serafini; João Pereira Leite
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

9.  Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion.

Authors:  Ludmyla Kandratavicius; Mariana Raquel Monteiro; Jaime Eduardo Hallak; Carlos Gilberto Carlotti; Joao Alberto Assirati; Joao Pereira Leite
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

10.  Neural fragility as an EEG marker of the seizure onset zone.

Authors:  Jorge Gonzalez-Martinez; Sridevi V Sarma; Adam Li; Chester Huynh; Zachary Fitzgerald; Iahn Cajigas; Damian Brusko; Jonathan Jagid; Angel O Claudio; Andres M Kanner; Jennifer Hopp; Stephanie Chen; Jennifer Haagensen; Emily Johnson; William Anderson; Nathan Crone; Sara Inati; Kareem A Zaghloul; Juan Bulacio
Journal:  Nat Neurosci       Date:  2021-08-05       Impact factor: 24.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.